Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH

13.83

-4.95(-26.36%)

Updated at June 03 11:29AM

Currency In CNY

Valuation

Market Cap8.49B
Enterprise Value8.5B
P/E Ratio-393.46
PEG Ratio8.44
Price/Sales Ratio3.89
Price/Book Ratio1.52
Enterprise/Revenue3.94
Enterprise/EBITDA171.56

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin-0.03

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue1.38B
Revenue/Share3.38
Gross Profit-40.48M
EBITDA56.88M
Net Income-16.97M
Diluted EPS-0.04

Balance Sheet

Total Cash2.94B
Total Cash/Share7.03
Total Debt972M
Total Debt/Equity0.26
Current Ratio3.39
Book Value Per Share9.07

Price History

52-Week Change-39.9
52-Week High20.59
52-Week Low13.72
Moving Average 50 Days15.2
Moving Average 200 Days16.38

Statistics

Average Volume2.64M
Shares Outstanding397.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.65
Trailing Annual Dividend Yield4.7
Payout Ratio-5.13
Last Split Factor13:10
Last Split DateJune 03, 2026